Estrogen receptor modulators

Details for Australian Patent Application No. 2005267210 (hide)

Owner Merck & Co., Inc.

Inventors Gude, Candido; Blizzard, Timothy A.

Agent Spruson & Ferguson

Pub. Number AU-A-2005267210

PCT Pub. Number WO2006/012333

Priority 60/584,228 30.06.04 US

Filing date 24 June 2005

Wipo publication date 2 February 2006

International Classifications

C07J 1/00 (2006.01) Normal steroids, i.e. cyclopenta[a]hydrophenanthrenes, containing carbon, hydrogen, halogen, or oxygen

A61K 31/56 (2006.01) - Compounds containing cyclopenta[a]hydrophenanthrene ring systems

Event Publications

11 January 2007 PCT application entered the National Phase

  PCT publication WO2006/012333 Priority application(s): WO2006/012333

2 July 2009 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired

  This application lapsed under section 142(2)(a). A direction to request examination has been given for this application. Note that applications or patents shown as lapsed or ceased may be restored at a later date.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2005267227-Methods involving micromosal prostaglandin E2 synthase

2005267202-Delta-8 desaturase and its use in making polyunsaturated fatty acids